Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression / 南方医科大学学报
Journal of Southern Medical University
; (12): 647-649, 2007.
Article
em Zh
| WPRIM
| ID: wpr-268057
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To establish a nude mouse model of malignant ascites with human ovarian carcinoma cell line OVCAR3 which highly expresses VEGF and evaluate the therapeutic of Avastin combined with cisplan.</p><p><b>METHODS</b>Forty-eight nude mice with malignant ascites resulting from intraperitoneal transplantation of human ovarian carcinoma cell line OVCAR3 were treated with intraperitoneal injection of Avastin, cisplan, their combination, and PBS, respectively, to observe the effect on ascites development, VEGF content in the ascites, peritoneal permeability, development of new vessels and number of tumor cells in the ascites.</p><p><b>RESULTS</b>Avastin obviously inhibited ascites accumulation and peritoneal capillary permeability, reduced VEGF protein level and microvascular density in the tumor tissues and the number of red cells and tumor cells in the malignant ascites, and prolonged the survival of the mice. The combination of Avastin and cisplan further enhanced the therapeutic efficacy of Avastin.</p><p><b>CONCLUSION</b>The bio-chemotherapeutic strategy with Avastin combined with cisplan can be a promising method for treatment of malignant ascites.</p>
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Neoplasias Ovarianas
/
Patologia
/
Ascite
/
Ensaio de Imunoadsorção Enzimática
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Regulação Neoplásica da Expressão Gênica
/
Cisplatino
/
Resultado do Tratamento
/
Reação em Cadeia da Polimerase Via Transcriptase Reversa
/
Ensaios Antitumorais Modelo de Xenoenxerto
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Female
/
Humans
Idioma:
Zh
Ano de publicação:
2007
Tipo de documento:
Article